Beijing StarMab's SM2275 Receives FDA IND Approval for Dual-Target Cancer Therapy
CompanyDrug

Beijing StarMab’s SM2275 Receives FDA IND Approval for Dual-Target Cancer Therapy

GE Healthcare Appoints Jeannette Bankes as President and CEO of Patient Care Solutions
Company

GE Healthcare Appoints Jeannette Bankes as President and CEO of Patient Care Solutions

Wantai Bio's Tuberculosis Test Kit Joins UNOPS StopTB Procurement List
CompanyMedical Device

Wantai Bio’s Tuberculosis Test Kit Joins UNOPS StopTB Procurement List

B. Braun's DUPLEX System Approved by FDA for Piperacillin and Tazobactam
CompanyDrug

B. Braun’s DUPLEX System Approved by FDA for Piperacillin and Tazobactam

Sino Biopharma's TQB3019 Gains NMPA Approval for Hematological Malignancies
CompanyDrug

Sino Biopharma’s TQB3019 Gains NMPA Approval for Hematological Malignancies

Peijia Medical's YonFlow Stent Approved by China's NMPA
CompanyMedical Device

Peijia Medical’s YonFlow Stent Approved by China’s NMPA

Gaush Meditech's Corneal Confocal Microscope Approved in Jiangsu
CompanyMedical Device

Gaush Meditech’s Corneal Confocal Microscope Approved in Jiangsu

Simcere Pharmaceutical Gains NMPA Approval for FGFR2b-Targeted ADC SIM0686
CompanyDrug

Simcere Pharmaceutical Gains NMPA Approval for FGFR2b-Targeted ADC SIM0686

Sinopep-Allsino Partners with Gulf Pharmaceutical for Semaglutide API Supply
CompanyDeals

Sinopep-Allsino Partners with Gulf Pharmaceutical for Semaglutide API Supply

Policy Analysis & Guidance: U.S. Tariffs on Pharmaceuticals and Their Impact on China's Medical Industry
Policy / Regulatory

U.S. Tariffs on Pharmaceuticals and Their Impact on China’s Medical Industry

Sichuan Biokin Launches Phase III Trial for BL-B01D1 in Urothelial Carcinoma
CompanyDrug

Sichuan Biokin Launches Phase III Trial for BL-B01D1 in Urothelial Carcinoma

AbbVie's Rinvoq Approved in EU for Giant Cell Arteritis
CompanyDrug

AbbVie’s Rinvoq Approved in EU for Giant Cell Arteritis